---
title: Successful Affinity-Based Lead Identification and Optimization for Challenging Targets and Ligands
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/SpotMe%20Online%20Symposia/Technology%20Networks/2021/Drug%20Discovery%20-%20October%2028-29/2021_DrugDiscoveryOS_050721_LA-V2-2000x1000.png
---

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

![TN White.jpg](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20White.jpg.png?width=400&height=44&name=TN%20White.jpg.png "TN White.jpg")

![nanotemper-white](https://go.technologynetworks.com/hs-fs/hubfs/nanotemper-white.png?width=2700&name=nanotemper-white.png "nanotemper-white")

# Successful Affinity-Based Lead Identification and Optimization for Challenging Targets and Ligands

Webinar

It’s not by chance that biophysical methods are becoming an integral part of drug discovery workflows. Targets are becoming more diverse and challenging, demand for fragment-based screening projects is increasing, and the need to identify ligands with different mechanisms of action is rising. Biophysical methods can overcome the obstacles faced with challenging targets and ligands during lead identification. If your screening campaigns are running into similar roadblocks, join us for this talk where we’ll present examples of successful biophysical characterization of binding events during affinity-based screenings that include challenging ligands and targets.

**During this talk we discuss:**

- Current trends and challenges in drug discovery and development
- Affinity-based screenings case studies for challenging ligands and targets

**Speaker Information:**

![WebinarSpeakerImage_A-Gupta](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/SpotMe%20Online%20Symposia/Technology%20Networks/2021/Drug%20Discovery%20-%20October%2028-29/WebinarSpeakerImage_A-Gupta.png?width=143&name=WebinarSpeakerImage_A-Gupta.png)

Amit J. Gupta, PhD  
Global Product Manager  
Nanotemper Technologies

 

 

**During this talk we discuss:**

- Current trends and challenges in drug discovery and development
- Affinity-based screenings case studies for challenging ligands and targets

Watch for FREE Now!

.

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

Technology Networks Limited   
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK   
Email: privacy@technologynetworks.com   
© 2022 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)